世界の貧血治療市場規模・現状・予測2021-2027

【英語タイトル】Global Anemia Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0323)・商品コード:QY21APR0323
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥998,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、貧血治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・貧血治療の市場動向
・企業の競争状況、市場シェア
・貧血治療の種類別市場規模(鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血)
・貧血治療の用途別市場規模(病院、クリニック、その他)
・貧血治療の北米市場規模2016-2027(アメリカ、カナダ)
・貧血治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・貧血治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・貧血治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・貧血治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Sanofi、Acceleron Pharma、Bayer、GlaxoSmithKline、Novartis、Pieris Pharmaceuticals、AMAG Pharmaceuticals、Daiichi Sankyo、Galenica、Pharmacosmos)
・結論
【レポートの概要】

Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia.
The iron deficiency anemia market segment accounted for the major shares of the anemia drugs market during 2017. The prevalence of iron deficiency anemia is increasing in the developing as well as developed countries. Also, around 5% women and 2% men in America are affected by the iron deficiency anemia as per the National Institutes of Health (NIH)

Market Analysis and Insights: Global Anemia Therapeutics Market
The global Anemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anemia Therapeutics market.

Global Anemia Therapeutics Scope and Market Size
Anemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Iron Deficiency Anemia
Sickle Cell Anemia
Pernicious Anemia
Hemolytic Anemia

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Acceleron Pharma
Bayer
GlaxoSmithKline
Novartis
Pieris Pharmaceuticals
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Iron Deficiency Anemia
1.2.3 Sickle Cell Anemia
1.2.4 Pernicious Anemia
1.2.5 Hemolytic Anemia
1.3 Market by Application
1.3.1 Global Anemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anemia Therapeutics Market Perspective (2016-2027)
2.2 Anemia Therapeutics Growth Trends by Regions
2.2.1 Anemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Anemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Anemia Therapeutics Industry Dynamic
2.3.1 Anemia Therapeutics Market Trends
2.3.2 Anemia Therapeutics Market Drivers
2.3.3 Anemia Therapeutics Market Challenges
2.3.4 Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anemia Therapeutics Players by Revenue
3.1.1 Global Top Anemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Anemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anemia Therapeutics Revenue
3.4 Global Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anemia Therapeutics Revenue in 2020
3.5 Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anemia Therapeutics Breakdown Data by Type
4.1 Global Anemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Anemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Anemia Therapeutics Breakdown Data by Application
5.1 Global Anemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Anemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anemia Therapeutics Market Size (2016-2027)
6.2 North America Anemia Therapeutics Market Size by Type
6.2.1 North America Anemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Anemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Anemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Anemia Therapeutics Market Size by Application
6.3.1 North America Anemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Anemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Anemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Anemia Therapeutics Market Size by Country
6.4.1 North America Anemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Anemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anemia Therapeutics Market Size (2016-2027)
7.2 Europe Anemia Therapeutics Market Size by Type
7.2.1 Europe Anemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Anemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Anemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Anemia Therapeutics Market Size by Application
7.3.1 Europe Anemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Anemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Anemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Anemia Therapeutics Market Size by Country
7.4.1 Europe Anemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Anemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Anemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Anemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Anemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Anemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Anemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Anemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anemia Therapeutics Market Size (2016-2027)
9.2 Latin America Anemia Therapeutics Market Size by Type
9.2.1 Latin America Anemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Anemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Anemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Anemia Therapeutics Market Size by Application
9.3.1 Latin America Anemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Anemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Anemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Anemia Therapeutics Market Size by Country
9.4.1 Latin America Anemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Anemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Anemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Anemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Anemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Anemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Anemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Anemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anemia Therapeutics Introduction
11.1.4 Sanofi Revenue in Anemia Therapeutics Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Acceleron Pharma
11.2.1 Acceleron Pharma Company Details
11.2.2 Acceleron Pharma Business Overview
11.2.3 Acceleron Pharma Anemia Therapeutics Introduction
11.2.4 Acceleron Pharma Revenue in Anemia Therapeutics Business (2016-2021)
11.2.5 Acceleron Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Anemia Therapeutics Introduction
11.3.4 Bayer Revenue in Anemia Therapeutics Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anemia Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Anemia Therapeutics Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Anemia Therapeutics Introduction
11.5.4 Novartis Revenue in Anemia Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pieris Pharmaceuticals
11.6.1 Pieris Pharmaceuticals Company Details
11.6.2 Pieris Pharmaceuticals Business Overview
11.6.3 Pieris Pharmaceuticals Anemia Therapeutics Introduction
11.6.4 Pieris Pharmaceuticals Revenue in Anemia Therapeutics Business (2016-2021)
11.6.5 Pieris Pharmaceuticals Recent Development
11.7 AMAG Pharmaceuticals
11.7.1 AMAG Pharmaceuticals Company Details
11.7.2 AMAG Pharmaceuticals Business Overview
11.7.3 AMAG Pharmaceuticals Anemia Therapeutics Introduction
11.7.4 AMAG Pharmaceuticals Revenue in Anemia Therapeutics Business (2016-2021)
11.7.5 AMAG Pharmaceuticals Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Anemia Therapeutics Introduction
11.8.4 Daiichi Sankyo Revenue in Anemia Therapeutics Business (2016-2021)
11.8.5 Daiichi Sankyo Recent Development
11.9 Galenica
11.9.1 Galenica Company Details
11.9.2 Galenica Business Overview
11.9.3 Galenica Anemia Therapeutics Introduction
11.9.4 Galenica Revenue in Anemia Therapeutics Business (2016-2021)
11.9.5 Galenica Recent Development
11.10 Pharmacosmos
11.10.1 Pharmacosmos Company Details
11.10.2 Pharmacosmos Business Overview
11.10.3 Pharmacosmos Anemia Therapeutics Introduction
11.10.4 Pharmacosmos Revenue in Anemia Therapeutics Business (2016-2021)
11.10.5 Pharmacosmos Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Iron Deficiency Anemia
Table 3. Key Players of Sickle Cell Anemia
Table 4. Key Players of Pernicious Anemia
Table 5. Key Players of Hemolytic Anemia
Table 6. Global Anemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Anemia Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Anemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Anemia Therapeutics Market Share by Regions (2022-2027)
Table 12. Anemia Therapeutics Market Trends
Table 13. Anemia Therapeutics Market Drivers
Table 14. Anemia Therapeutics Market Challenges
Table 15. Anemia Therapeutics Market Restraints
Table 16. Global Anemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Anemia Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Therapeutics as of 2020)
Table 19. Ranking of Global Top Anemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Anemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anemia Therapeutics Product Solution and Service
Table 23. Date of Enter into Anemia Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Anemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Anemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Anemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Anemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Anemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Anemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Anemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Anemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Anemia Therapeutics Product
Table 66. Sanofi Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Acceleron Pharma Company Details
Table 69. Acceleron Pharma Business Overview
Table 70. Acceleron Pharma Anemia Therapeutics Product
Table 71. Acceleron Pharma Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Acceleron Pharma Recent Development
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Anemia Therapeutics Product
Table 76. Bayer Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Bayer Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Anemia Therapeutics Product
Table 81. GlaxoSmithKline Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Anemia Therapeutics Product
Table 86. Novartis Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pieris Pharmaceuticals Company Details
Table 89. Pieris Pharmaceuticals Business Overview
Table 90. Pieris Pharmaceuticals Anemia Therapeutics Product
Table 91. Pieris Pharmaceuticals Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Pieris Pharmaceuticals Recent Development
Table 93. AMAG Pharmaceuticals Company Details
Table 94. AMAG Pharmaceuticals Business Overview
Table 95. AMAG Pharmaceuticals Anemia Therapeutics Product
Table 96. AMAG Pharmaceuticals Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 97. AMAG Pharmaceuticals Recent Development
Table 98. Daiichi Sankyo Company Details
Table 99. Daiichi Sankyo Business Overview
Table 100. Daiichi Sankyo Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Daiichi Sankyo Recent Development
Table 102. Galenica Company Details
Table 103. Galenica Business Overview
Table 104. Galenica Anemia Therapeutics Product
Table 105. Galenica Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Galenica Recent Development
Table 107. Pharmacosmos Company Details
Table 108. Pharmacosmos Business Overview
Table 109. Pharmacosmos Anemia Therapeutics Product
Table 110. Pharmacosmos Revenue in Anemia Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Pharmacosmos Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Iron Deficiency Anemia Features
Figure 3. Sickle Cell Anemia Features
Figure 4. Pernicious Anemia Features
Figure 5. Hemolytic Anemia Features
Figure 6. Global Anemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Anemia Therapeutics Report Years Considered
Figure 11. Global Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Anemia Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Anemia Therapeutics Market Share by Players in 2020
Figure 16. Global Top Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anemia Therapeutics Revenue in 2020
Figure 18. Global Anemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Anemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anemia Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Anemia Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Anemia Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anemia Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Anemia Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Anemia Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anemia Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anemia Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anemia Therapeutics Market Share by Region (2016-2027)
Figure 40. China Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anemia Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Anemia Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Anemia Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anemia Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anemia Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anemia Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 60. Acceleron Pharma Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 64. Pieris Pharmaceuticals Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 65. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 66. Daiichi Sankyo Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 67. Galenica Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 68. Pharmacosmos Revenue Growth Rate in Anemia Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

Sanofi、Acceleron Pharma、Bayer、GlaxoSmithKline、Novartis、Pieris Pharmaceuticals、AMAG Pharmaceuticals、Daiichi Sankyo、Galenica、Pharmacosmos

★調査レポート[世界の貧血治療市場規模・現状・予測2021-2027] (コード:QY21APR0323)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の貧血治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆